Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/El Paso
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in El Paso, TX

Studies commonly pay $75 to $4,500 per completed study

194 clinical trials are currently recruiting participants within 30 miles of El Paso. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

194studies recruiting
5+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near El Paso right now

Top 25 of 194 recruiting studies, sorted by proximity — each links to its official registry page

Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS

COPD, Smoking N/A Interventional 290 participants sought
El Paso Pulmonary Association — El Paso, Texas (7.0 mi) · Sponsor: Philip Morris Products S.A.

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 800 participants sought
Texas Oncology - West Texas — El Paso, Texas (7.0 mi) · Sponsor: Eli Lilly and Company

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

Juvenile Psoriatic Arthritis Phase 1 Interventional 20 participants sought
Texas Arthritis Center — El Paso, Texas (7.0 mi) · Sponsor: Novartis Pharmaceuticals

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Breast Cancer Phase 3 Interventional 400 participants sought
Texas Oncology-West Texas — El Paso, Texas (7.0 mi) · Sponsor: Pfizer

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Phase 2 Interventional 48 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Hypothyroidism Phase 2, Phase 3 Interventional 2,800 participants sought
Academy of Diabetes, Thyroid and Endocrine /ID# 255735 — El Paso, Texas (7.0 mi) · Sponsor: AbbVie

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Systemic Lupus Erythematosus (SLE) N/A Observational 223 participants sought
El Paso Medical Research Institute (MedResearch, Inc) — El Paso, Texas (7.0 mi) · Sponsor: Bristol-Myers Squibb

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) Phase 2 Interventional 40 participants sought
3A Research Llc West Location — El Paso, Texas (7.0 mi) · Sponsor: Incyte Corporation

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion Phase 2 Interventional 84 participants sought
El Paso Kidney Specialists- Site Number : 8400005 — El Paso, Texas (7.0 mi) · Sponsor: Sanofi

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Metastatic Non-small Cell Lung Cancer With MTAP Deletion Phase 2, Phase 3 Interventional 590 participants sought
Local Institution - 0374 — El Paso, Texas (7.0 mi) · Sponsor: Bristol-Myers Squibb

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

Lupus Nephritis Phase 2 Interventional 40 participants sought
Texas Arthritis Center — El Paso, Texas (7.0 mi) · Sponsor: Hoffmann-La Roche

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Triple Negative Breast Cancer Phase 3 Interventional 1,514 participants sought
Texas Oncology — El Paso, Texas (7.0 mi) · Sponsor: Gilead Sciences

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Systemic Lupus Erythematosus Phase 3 Interventional 100 participants sought
Research Site — El Paso, Texas (7.0 mi) · Sponsor: AstraZeneca

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Generalized Myasthenia Gravis Phase 3 Interventional 264 participants sought
ANESC Research — El Paso, Texas (7.0 mi) · Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer, Locally Advanced Breast Cancer Phase 3 Interventional 1,000 participants sought
Clinical Trial Site — El Paso, Texas (7.0 mi) · Sponsor: Olema Pharmaceuticals, Inc.

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Solid Tumor, Non-Small Cell Lung Cancer Phase 1, Phase 2 Interventional 340 participants sought
Renovatio Clinical - El Paso — El Paso, Texas (7.0 mi) · Sponsor: Inhibrx Biosciences, Inc

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Growth Hormone Deficiency N/A Observational 900 participants sought
Ascendis Investigational Site — El Paso, Texas (7.0 mi) · Sponsor: Ascendis Pharma Endocrinology Division A/S

Gastroparesis Registry 4

Gastroparesis, Gastroparesis Nondiabetic N/A Observational 250 participants sought
Texas Tech University Health Science Center (TTUHSC) — El Paso, Texas (7.0 mi) · Sponsor: Johns Hopkins Bloomberg School of Public Health

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Low Grade Astrocytoma, Low Grade Glioma Phase 3 Interventional 170 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi) · Sponsor: National Cancer Institute (NCI)
Actively enrolling

Studies you may be able to join near El Paso

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in El Paso

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Headlands Research El Paso

★ 4.9
1600 Medical Center St #307, El Paso, TX 79902
(915) 910-7088
"Ashley was great and made the process stress free. Clean, bright office and everything went smooth ."
— Josh Ua, 5★

Western Sky Medical Research

★ 4.3
2121 Wyoming Ave, El Paso, TX 79903
(915) 544-2557
"I want people to know the service here is horrible. That is why I deleted the novel of complaints I had about this place. FYI we were referred from b…"
— Mitchell Rold, 1★

El Paso Clinical Trials

★ 5.0
1729 Weston Brent Ln, El Paso, TX 79935
(915) 247-2309
"Excellent clinic, the customer service is superb! I highly recommend it!"
— Jesse Nava, 5★

El Paso Medical Research Institute (MedResearch, INC.)

1201 E Schuster Ave Ste 1A, El Paso, TX 79902
(915) 307-4669

El Paso Research

★ 5.0
1618 Lee Trevino Dr B, El Paso, TX 79936
(915) 257-7737
"I had a great experience with El Paso Research! Professional & knowledgable team and beautiful facility. Highly recommend to anyone interested in con…"
— Josh Mendoza, 5★

Clinical trials in El Paso: what's recruiting

The El Paso area currently has 194 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to El Paso, the most active research areas are:

  • Cancer & Oncology7 studies
  • Immune & Skin4 studies
  • Lungs & Breathing2 studies
  • Diabetes & Metabolism2 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from El Paso, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in El Paso

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

El Paso participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in El Paso?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in El Paso safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in El Paso?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in El Paso typically complete one or two studies per year.

Paid clinical trials near El Paso

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of TX

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts